Medicare patients’ out-of-pocket costs for insulin decrease under mandated caps
A new analysis led by researchers at the Johns Hopkins Bloomberg School of Public Health finds that out-of-pockets caps on insulin for Medicare Part D beneficiaries have reined… read more.




